[BrokerRatings]Analyst Ratings Roundup: Tech, Industrials, and Biotech Gain Momentum, Software and Pharma Face Downgrades

Technology and Industrials lead with recent strong buy ratings on Monday, August 11, for large-cap names like ARM and CMI. On Thursday, August 7, Healthcare giant ABBV and Energy major BP also received strong buy upgrades. The Healthcare/Biotech sector shows strong momentum with new strong buys including ARWR, CBIO, and COLL on Monday, August 11. However, caution is advised in software and fintech as AI faced a strong sell downgrade on Monday, August 11, and XYZ on Friday, August 8, while pharma giant LLY was downgraded to Hold on Thursday, August 7.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.

Summary Snippets